Early Life and Education
Lee Sang-hoon was born in South Korea in January 1963. From 1982 to 1989, he studied biology at Seoul National University, earning a Bachelor of Science and a Master's degree in developmental biology. He then completed a Ph.D. in Molecular, Cellular and Developmental Biology at Ohio State University in 1994. He also completed postdoctoral fellowships at Harvard Medical School, the University of California, San Francisco, and Stanford Medical School.
Rise to Success
Lee's career includes significant experience in the biotech and pharmaceutical sectors. He held research positions at several companies, including AstraZeneca, Genentech, and Exelixis. In 2008, Lee co-founded PharmAbcine. He later served as the head of the biotech division at Hanwha Solutions. His biggest achievement to date is founding ABL Bio in 2016. The company went public on the KOSDAQ in 2018. In 2025, Lee became a billionaire after ABL Bio signed a licensing and research agreement with Eli Lilly.
Key Business Strategies
ABL Bio focuses on the development of bispecific antibodies, which target two molecules simultaneously to improve treatment outcomes for cancer and neurodegenerative diseases. The company has advanced four bispecific antibodies into clinical trials. ABL Bio has signed deals with companies like Eli Lilly, and GSK to develop new therapies. Lee's strategy centers around innovation in antibody technology and strategic partnerships.
Philanthropy
I am sorry, but information regarding the specific philanthropy amounts is not available in the search results.
